Abbott Tries Again To Sink HIV Test Patent

By Andrew Karpan (November 22, 2022, 6:30 PM EST) -- Abbott Laboratories says that a Novartis patent covering a method for replicating DNA that allegedly was used in its HIV tests should never have been issued in the first place, since it cites patent paperwork that dates to 1984, when "the scientific community had much to learn about AIDS."...

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!